(A) BTIC-10 cells were treated with Sunitinib at indicated concentrations or Tunicamycin (Tm.) at 0.5 μg/ml for 24 hours. Nuclear protein extracts were subjected to Western Blot analysis. Histon H3 was used as loading control. (B) Whole cell protein lysates were prepared from 18 BTIC cultures. For Western Blot analysis 30 µg of total protein/BTIC culture were used. Expression intensity of PDGF Receptor-α and PDGF Receptor-β were graded as follows by three independent investigators: ++ strong, + moderate, 0 not expressed. Intensities of PDGF Receptor were plotted against proliferation after Sunitinib treatment (1 µM) for 18 BTICs. Proliferation after Sunitinib treatment was normalized to the respective control (DMSO) and published elsewhere [21].

